Genetic microevolution of clinical <i>Candida auris</i> with reduced Amphotericin B sensitivity in China-Reference-Cited by-同舟云学术

Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China

Published:2024-09-09 Issue:1 Volume:13 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Tian Sufei¹,Rong Chen¹,Li Hailong¹²,Wu Yusheng¹,Wu Na³,Chu Yunzhuo¹,Jiang Ning¹,Zhang Jingping³,Shang Hong¹²

Affiliation:

1. National Clinical Research Center for Laboratory Medicine, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Department of Laboratory Medicine, the First Hospital of China Medical University, Shenyang, People’s Republic of China

2. NHC Key Laboratory of AIDS Prevention and Treatment, The First Hospital of China Medical University, China Medical University, Shenyang, People’s Republic of China

3. Department of Infectious Diseases, the First Hospital of China Medical University, Shenyang, People’s Republic of China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2024.2398596

Reference34 articles.

1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

2. Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B

3. ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait

4. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris

5. Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr